๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia flag Malaysia ยท Delayed Price ยท Currency is MYR
1.030
-0.050 (-4.63%)
At close: Nov 20, 2026

Duopharma Biotech Berhad Financials Overview

Millions MYR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
916.98931.69813.7704.73696.72639.18
Revenue Growth
1.81%14.50%15.46%1.15%9.00%12.16%
Gross Profit
394.01363.14301.54268.33279.82253.98
Operating Income
158.34133.78100.2678.7192.9188.77
Net Income
107.6187.4662.6552.6570.1165.68
Earnings Per Share
0.110.090.070.050.070.07
EPS Growth
28.89%39.62%18.57%-25.71%4.50%12.05%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Malaysia
871.83754.18650.55654.89596.89
Export
59.8759.5154.1841.8342.29
Total
931.69813.7704.73696.72639.18

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
181.2290.87264.55270.5157.64137.98
Total Debt
370.68496.08515.82548.85431.6403.84
Net Cash (Debt)
-189.48-205.21-251.28-278.35-273.97-265.86
Net Cash Growth
------
Net Cash Per Share
-0.20-0.21-0.26-0.29-0.29-0.29

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
101.29106.8383.3448.870.2743.2
Capital Expenditures
-22.57-26.84-23.57-32.95-65.18-109.36
Free Cash Flow
78.7279.9959.7715.865.08-66.16
Free Cash Flow Growth
-1.76%33.83%276.91%211.98%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
42.97%38.98%37.06%38.07%40.16%39.74%
Operating Margin
17.27%14.36%12.32%11.17%13.33%13.89%
Pretax Margin
15.41%12.33%9.83%8.98%12.18%12.98%
Profit Margin
11.74%9.39%7.70%7.47%10.06%10.28%
FCF Margin
8.58%8.59%7.35%2.25%0.73%-10.35%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0450.0450.0300.0230.0230.022
Dividend Per Share Growth
30.00%51.67%30.44%0%5.75%-55.43%
Dividend Yield
4.42%3.64%2.40%1.82%1.43%1.29%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.2013.7519.1923.0221.8724.09
Forward PE
9.1812.0814.7414.7715.9120.97
P/FCF Ratio
12.5915.0320.1276.43301.61-
PS Ratio
1.081.291.481.722.202.48